ClinicalTrials.gov
ClinicalTrials.gov Menu

Hemodynamic and Biological Evaluations During Reventilation Collapse in ICU (REVECOL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01785654
Recruitment Status : Unknown
Verified February 2013 by University Hospital, Clermont-Ferrand.
Recruitment status was:  Not yet recruiting
First Posted : February 7, 2013
Last Update Posted : February 7, 2013
Sponsor:
Information provided by (Responsible Party):
University Hospital, Clermont-Ferrand

Brief Summary:
Prospective, observational clinical multicentric study in ICU; during the period surrounding the orotracheal intubation.

Condition or disease
Arterial Line Consent of Patients Adult Patients Tracheal Intubation in ICU

Detailed Description:

Main objective: to describe the characteristics of reventilation collapse: collapse rate, duration and treatment implemented

Secondary objectives:

  • identify risk factors of reventilation collapse
  • compare mortality, hemodynamic, respiratory, infectious and biological data between collapse group and no reventilation collapse group.

Study Type : Observational
Estimated Enrollment : 400 participants
Official Title: Hemodynamic and Biological Evaluations During Reventilation Collapse in ICU
Study Start Date : March 2013
Estimated Primary Completion Date : November 2014
Estimated Study Completion Date : December 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Shock

Group/Cohort
reventilation collapse



Primary Outcome Measures :
  1. Reventilation collapse [ Time Frame: at day 1 (at least thirty minutes despite 500 or 1000ml of fluid resuscitation) ]

Secondary Outcome Measures :
  1. reventilation collapse [ Time Frame: in the last 72 hours ]
  2. Duration of mechanical ventilation [ Time Frame: at day 1 ]
  3. mortality [ Time Frame: at day 28 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Defined population
Criteria

Inclusion Criteria:

  • Arterial line
  • Consent of patients
  • Adult patients
  • Tracheal intubation in ICU

Exclusion Criteria:

  • tracheal intubation for cardiac arrest
  • pregnant woman
  • major protected

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01785654


Contacts
Contact: Patrick LACARIN 04 73 75 11 95 placarin@chu-clermontferrand.fr

Locations
France
CHU Clermont-Ferrand Not yet recruiting
Clermont-Ferrand, France, 63003
Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr   
Sponsors and Collaborators
University Hospital, Clermont-Ferrand
Investigators
Principal Investigator: Sebastien PERBET University Hospital, Clermont-Ferrand

Responsible Party: University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier: NCT01785654     History of Changes
Other Study ID Numbers: CHU-0142
DC-2012-1501
First Posted: February 7, 2013    Key Record Dates
Last Update Posted: February 7, 2013
Last Verified: February 2013

Keywords provided by University Hospital, Clermont-Ferrand:
Reventilation collapse
Rate of reventilation collapse
Risk factor of reventilation collapse
Hemodynamic profile of reventilation collapse
Biologic approach of reventilation collapse

Additional relevant MeSH terms:
Shock
Pathologic Processes